Provider review
June Health review
Advertises a headline that matches neither drug it sells, and quotes both at two prices.
Reviewed by Lena OrtizMetabolic Health Editor
Price updated August 2026
We may earn a commission at no extra cost to you. Affiliate partners are listed first on our rankings. How we’re funded.
$187/mo sema · $249/mo tirz, and a $199 headline matching neither
Visit June HealthThe homepage offers weight loss from one figure while the product cards price semaglutide and tirzepatide at two others, and a second page quotes both again at a third. Three numbers, two drugs, one site.
Price as published
June Health
$187/mo sema · $249/mo tirz, and a $199 headline matching neither
- Vs median
- $12/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
In one paragraph
The verdict
Three different numbers describe this catalog and no two of them agree. The homepage headline offers medical weight loss from one figure. The cards underneath price semaglutide from a lower one and tirzepatide from a higher one, so the headline matches neither — it sits above the first and well below the second, and anyone anchoring on it will be wrong about both drugs in opposite directions. Then the weight-loss page quotes those same two products at a third figure again. Nothing anywhere on the site reconciles them. For the question this site exists to answer, the arithmetic cannot even start: you cannot work out what a small dose costs when you cannot establish what the drug costs. What holds up is worth noting. Both molecules are priced separately rather than hidden behind one blended number, coverage is stated as all fifty states rather than left vague, shipping is free, and the wider catalog is priced openly alongside. But every GLP-1 figure is a "from", none has a dose behind it, and a floor quoted at two different depths on one site is not information a reader can use.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
Who it suits, and who it does not
A good fit if
- You want both molecules priced separately rather than behind one blended figure.
- You want coverage stated plainly — all fifty states, with free shipping.
- You want the sermorelin and NAD+ lines priced openly on the same site.
Look elsewhere if
- You need one reliable price. The same two products are quoted at two different floors.
- You anchor on the headline figure. It matches neither drug on the site.
- You are pricing a dose. None is published behind any figure.
What it actually costs
Price as published
$187/mo sema · $249/mo tirz, and a $199 headline matching neither
- Vs median
- $12/mo above the $175 median across the 299 of 548 programs here that publish a plain monthly rate
- Market
- $59–$1,300/mo is the full published spread on this site
- Structure
- Standard plan, self-directed low dose
No low-dose product of its own. Starting low means asking for a smaller amount inside a standard plan, at the standard plan's price.
235 of the 548 programs here price a small dose this way. Each molecule carries a figure, but each carries two different ones across the site, and the homepage headline matches neither. A price quoted at two different floors on two pages of one site is not one you can plan around before intake, even though figures are visible. No low-dose product is offered.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
What is included
- Consult
- Included in the price
- Dietitian
- Not confirmed
- Labs
- Not required
- Pricing
- Check plan terms
What it does well
- Prices both molecules separately rather than behind one blended figure.
- Coverage is stated as all 50 states with free shipping rather than left unspecified.
- The non-GLP-1 catalog is priced openly alongside the weight-loss line.
Pharmacy, labs and oversight
June Health does not publicly identify the pharmacy that fills its prescriptions. No bloodwork is required before you start. A clinician review is included in the price.
Transparency check
1 of 4 published openly
What June Health publishes about itself, read from its own pages when we verified them — not estimated, and not a score.
- Pharmacy named and regulatedNo pharmacy is identified anywhere on its own pages.
- Not published
- A price you can read before intakeThe figure appears only after an intake quiz, so it cannot be compared before signing up.
- Not published
- What a higher dose costsPriced by dose, plan or tier, and the higher rungs are not published — the advertised figure does not tell you what a larger dose costs.
- Not published
- No FDA warning letter on fileChecked against the FDA's own warning-letter database; nothing on file for this company.
- None on file
How the program works
Three numbers describe the same catalog here and no two of them agree. The homepage headline offers medical weight loss from $199 a month. The product cards underneath price semaglutide from $187 and tirzepatide from $249, so the headline matches neither — it is above one and well below the other, and a reader anchoring on it will be wrong about both. Then the weight-loss page quotes those same two products at $179. That is three figures for two drugs across one site, and nothing on any page reconciles them. For a reader trying to work out what a low dose costs, the arithmetic cannot even begin. What is solid: coverage is stated as all 50 states rather than left vague, shipping is free, and the wider catalog including sermorelin and NAD+ is priced openly. But every GLP-1 figure is a "from", none has a dose behind it, and when the same product is quoted at two different floors on one site, a floor is not information.
The honest cons
The headline advertises a figure that matches neither drug the site sells.
- The same two products are quoted at two different prices on two pages of one site.
- Every GLP-1 figure is a "from" with no dose published behind it.
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
How it compares
June Health is one of 548 low-dose GLP-1 programs compared on this site, and 299 of them publish a monthly rate you can read before signing up. The full list puts every published price in one place, with the companies that pay us listed first — something we state there, on the page it applies to.
Also consider
Two more programs that price a small dose the way June Health does. Both are partners: we may earn a commission if you start care through these links.
Partner
Strut Health
$99/mo sema lozenge (auto-refill)
Standard plan, self-directed low dose
FDA warning letter · Strut Health · February 2026 · addressed to Strut Health, LLC dba Strut. Details in our review.
Partner
Peter MD
$149/mo GLP1+B12 · $249/mo tirz (quarterly)
Standard plan, self-directed low dose
Where this sits
#181 of 548
Ordered with the companies that pay us first, and June Health is not one of them. A disclosed partition, not a score.
Compare all 548 providers →Read this before you buy
Intentional GLP-1 microdosing is off-label and unproven — no randomized trial has established that a sub-label dose does anything, and any dose belongs with a clinician who knows your history. If you are going to have that conversation, have it with real numbers.
- What microdosing GLP-1 costs
- What the evidence actually shows
- The true annual cost of a plan
- What a flat price costs at a low dose
Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.
The closest alternative
HealthRX
$190/mo sema · $239/mo tirz (monthly plan)
- Vs median
- $15/mo above the $175 median
- Market
- $59–$1,300/mo across 299 of 548
- Structure
- Standard plan, self-directed low dose
- Dispensed
- Pharmacy not publicly identified
Advertising disclosure · we may earn a commission if you start care through some of these links, at no extra cost to you.
Read the HealthRX review →Microdosing is off-label and unproven — decide with a clinician. Prices are as published by the provider when we last checked; confirm current terms before you buy.